Opendata, web and dolomites

ALGABOOSTER SIGNED

Marine microalgae immunostimulant complex to boost the competitiveness of the EU aquaculture sector

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ALGABOOSTER" data sheet

The following table provides information about the project.

Coordinator
BUGGYPOWER SL 

Organization address
address: CALLE MIGUEL HERNANDEZ 16
city: SAN PEDRO DEL PINATAR
postcode: 30740
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BUGGYPOWER SL ES (SAN PEDRO DEL PINATAR) coordinator 50˙000.00

Map

 Project objective

The EU aquaculture sector is of high importance for the EU economy. However, EU aquaculture producers lag behind the global competitors that offer cheap products of much lower production costs and quality standards. In order to support EU producers in this highly competitive market, it is crucial to address their production inefficiencies: 20% mortality rates and long growth periods. The current solutions, namely use of antibiotics for mortality reduction and aquafeed with incorporated fishmeal and fish oil for improved growth, are inefficient, costly and extremely unsustainable. Consequently, there is a high need in the EU aquaculture sector for alternatives that can improve production efficiency in a sustainable, environmentallyfriendly and antibiotic-free manner.

In this context, and basing on the excellent properties of marine microalgae, we have developed ALGABOOSTER - advanced aquafeed enriched with marine microalgae immunostimulant complex to boost fish immune system and growth as well as buffer the effects of stress, all in a natural way.

The Unique Selling Points of ALGABOOSTER are:

(i) whole-cell microalgae complex of high purity biomass of three marine microalgae species, (ii) perfectly-preserved microalgae ingredient ensuring thanks to a novel microencausulation process ensuring premium quality product, (iii) safe in use as the functional ingredient is incorporated into aquafeed (no risk of overdose), (iv) 100% non-animal and sustainably sourced (no fishmeal, no fish oil), (v) adjusted to support normal feed in two growth stages

Our product has been scientifically tested and guarantees significant reduction in mortality rates and growth cycle duration as well as a substantial increase in quality of the final product. Via ALGABOOSTER´s administration, the production efficiency is enhanced, and aquaculture producers obtain a revolutionary increase in their profit margins.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALGABOOSTER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ALGABOOSTER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More  

MEDIVAC (2019)

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Read More